Cargando…

NAD(+): A key metabolic regulator with great therapeutic potential for myocardial infarction via Sirtuins family

Myocardial infarction (MI) is one of the complex phenotypes of coronary artery disease, which results from the interaction of multiple genetic and environmental factors. Nicotinamide Adenine Dinucleotide (NAD(+)) is an important cofactor regulating metabolic homeostasis and a rate-limiting substrate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Wei, Pei, Zuowei, Zhang, Xiaoqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663897/ https://www.ncbi.nlm.nih.gov/pubmed/38027748 http://dx.doi.org/10.1016/j.heliyon.2023.e21890

Ejemplares similares

Hypothalamic NAD(+)-Sirtuin Axis: Function and Regulation
por: Roh, Eun, et al.
Publicado: (2020)

NAD(+), Sirtuins and PARPs: enhancing oocyte developmental competence
por: POLLARD, Charley-Lea, et al.
Publicado: (2022)

Mechanism of CD38 via NAD(+) in the Development of Non-alcoholic Fatty Liver Disease
por: Dong, Min, et al.
Publicado: (2023)

Sirtuins: Sir2-related NAD-dependent protein deacetylases
por: North, Brian J, et al.
Publicado: (2004)

It takes two to tango: NAD(+) and sirtuins in aging/longevity control
por: Imai, Shin-ichiro, et al.
Publicado: (2016)

NAD Metabolism in Cancer Therapeutics
por: Yaku, Keisuke, et al.
Publicado: (2018)

NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential
por: Xie, Na, et al.
Publicado: (2020)

NAD(+) metabolism-based immunoregulation and therapeutic potential
por: Fang, Jiankai, et al.
Publicado: (2023)

Adipose tissue NAD(+)-homeostasis, sirtuins and poly(ADP-ribose) polymerases -important players in mitochondrial metabolism and metabolic health
por: Jokinen, Riikka, et al.
Publicado: (2017)

Sirtuin 1 as a key player of ‘metabolic memory’
por: Hashiramoto, Mitsuru, et al.
Publicado: (2013)

Neuroprotection of NAD(+) and NBP against ischemia/reperfusion brain injury is associated with restoration of sirtuin-regulated metabolic homeostasis
por: Wang, Xin-Xin, et al.
Publicado: (2023)

Molecular evolutionary patterns of NAD(+)/Sirtuin aging signaling pathway across taxa
por: Gaur, Uma, et al.
Publicado: (2017)

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction
por: Duran-Castells, Clara, et al.
Publicado: (2023)

Serum Sirtuin 1, 3 and 6 Levels in Acute Myocardial Infarction Patients
por: Kızıltunç, Emrullah, et al.
Publicado: (2019)

Sirtuin 1 in Chronic Kidney Disease and Therapeutic Potential of Targeting Sirtuin 1
por: Yan, Jiayi, et al.
Publicado: (2022)

NAD(+) metabolism is a key modulator of bacterial respiratory epithelial infections
por: Klabunde, Björn, et al.
Publicado: (2023)

Metabolic and Bactericidal Effects of Targeted Suppression of NadD and NadE Enzymes in Mycobacteria
por: Rodionova, Irina A., et al.
Publicado: (2014)

Elevated plasma Sirtuin2 level predicts heart failure after acute myocardial infarction
por: Zheng, Meili, et al.
Publicado: (2021)

Genetic Manipulation of Sirtuin 3 Causes Alterations of Key Metabolic Regulators in Melanoma
por: Singh, Chandra K., et al.
Publicado: (2021)

Sirtuin 6—A Key Regulator of Hepatic Lipid Metabolism and Liver Health
por: Dong, X. Charlie
Publicado: (2023)

Sirtuin 3 Dependent and Independent Effects of NAD(+) to Suppress Vascular Inflammation and Improve Endothelial Function in Mice
por: Cao, Xiaoyun, et al.
Publicado: (2022)

Sirtuins, Metabolism, and Cancer
por: Martinez-Pastor, Barbara, et al.
Publicado: (2012)

Regulation of metabolism by sirtuins
por: Haigis, Marcia
Publicado: (2012)

The role of the sirtuin family in cartilage and osteoarthritis: molecular mechanisms and therapeutic targets
por: Sun, Kaibo, et al.
Publicado: (2022)

The sirtuin family in health and disease
por: Wu, Qi-Jun, et al.
Publicado: (2022)

Sirtuin family in autoimmune diseases
por: Tao, Zhengjie, et al.
Publicado: (2023)

Cardiac metabolism as a driver and therapeutic target of myocardial infarction
por: Zuurbier, Coert J., et al.
Publicado: (2020)

DPP-4 inhibitor induces FGF21 expression via sirtuin 1 signaling and improves myocardial energy metabolism
por: Furukawa, Nozomi, et al.
Publicado: (2020)

Sirtuin activation as a therapeutic approach against inborn errors of metabolism
por: Bleeker, Jeannette C., et al.
Publicado: (2016)

New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials
por: Shi, Hong-tao, et al.
Publicado: (2022)

RNA therapeutics – The potential treatment for myocardial infarction
por: Chu, Hunghao, et al.
Publicado: (2016)

Metabolically distinct roles of NAD synthetase and NAD kinase define the essentiality of NAD and NADP in Mycobacterium tuberculosis
por: Sharma, Ritu, et al.
Publicado: (2023)

Emerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disorders
por: Srivastava, Sarika
Publicado: (2016)

NAD(+) Metabolism, Metabolic Stress, and Infection
por: Groth, Benjamin, et al.
Publicado: (2021)

Identification of key genes involved in myocardial infarction
por: Qiu, Linlin, et al.
Publicado: (2019)

Mammalian Sirtuins and Energy Metabolism
por: Li, Xiaoling, et al.
Publicado: (2011)

Sirtuins Link Inflammation and Metabolism
por: Vachharajani, Vidula T., et al.
Publicado: (2016)

Sirtuin and metabolic kidney disease
por: Wakino, Shu, et al.
Publicado: (2015)

Sirtuins and Immuno-Metabolism of Sepsis
por: Wang, Xianfeng, et al.
Publicado: (2018)

Sirtuins in glucose and lipid metabolism
por: Ye, Xin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cn5a1q4ei56v556gg9t8n43fo7